Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma.
Yamaguchi M, Hirai S, Sumi T, Tanaka Y, Tada M, Nishii Y, Hasegawa T, Uchida H, Yamada G, Watanabe A, Takahashi H, Sakuma Y.
Yamaguchi M, et al. Among authors: sumi t.
Biochem Biophys Res Commun. 2017 Jun 3;487(3):613-618. doi: 10.1016/j.bbrc.2017.04.102. Epub 2017 Apr 20.
Biochem Biophys Res Commun. 2017.
PMID: 28433633
Free PMC article.